Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Synthetic Biology Market Size Changed, over the years?

The market size of synthetic biology has seen exponential growth in recent years. The market, valued at $21.13 billion in 2024, is projected to increase to $26.7 billion in 2025 with a compound annual growth rate (CAGR) of 26.3%. The expansion in the historical period is due to the surge in healthcare and life science amenities, higher investment in pharmaceuticals, its extensive application in end-user sectors, affordable DNA sequencing and synthesizing, and an increase in funding.

How Much Will the Synthetic Biology Market Be Worth in 2029?

The market size for synthetic biology is predicted to expand rapidly in the upcoming years, reaching a value of $54.27 billion in 2029 with a compound annual growth rate (CAGR) of 19.4%. Within this forecast period, factors like increased government support, the search for alternative fuels, growing demand for genetically engineered crops, and rising private sector investment are credited for driving this growth. The forecast period is also expected to witness various key trends including strategic collaborations and partnerships, advancements in nucleotide synthesis and sequencing, an increased emphasis on gene editing, rising product innovation, higher acceptance of cell-free technology, and the development of new biofuel production processes that are more eco-friendly.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2508&type=smp

Which is the Largest Company in the Synthetic Biology Market?

Major companies operating in the synthetic biology market include Thermo Fisher Scientific Inc, Danaher Corporation, Eurofins Scientific, Merck KGaA, Novozymes A/S, Agilent Technologies, New England Biolabs Inc, Precigen Inc, Amyris, Inc, Genscript Biotech Corporation, Codex Genetics, Cathay Biotech, Bota Biosciences, Bluepha, Spiber, OriCiro Genomics Inc, Provectus Algae, Puraffinity, Royal DSM NV, Colorifix, Phytoform Labs, Desktop Genetics, NanoSyrinx, Pulmobiotics S.L, EnginZyme, Chain Biotech, Nuclera Nucleics, Biosynthetics GmbH, Entelechon GmbH, Sloning BioTechnology GmbH, Prokarium Ltd, Synbio, Captor Therapeutics, Gero.ai, ARNA Genomics, Solvo Omixon, Soft flow, Algenol, Genomatica, Integrated DNA Technologies, Sana Biotechnology, Impossible Foods, Apeel Sciences, Twist Bioscience, Synlogic, Zymergen Inc, Ginkgo Bioworks, Codexis, Arzeda Corporation, Synthetic Genomics, Conagen, Dupont, Oxitec Ltd, Sentebiolab, GEEN Biotechnology Inc, Genbiotek Biosistem Laboratory Ltd

What Are the Main Market Drivers in the Synthetic Biology Industry?

The synthetic biology market is anticipated to grow, fueled by the surge in research and development investment. This involves systematic exploration, ingenuity, and experimentation to expand the existing knowledge base, create new technologies, or develop products. The competition intensifies, the necessity for innovation grows, technological advancements occur rapidly, and businesses need to adapt to evolving customer preferences and market trends; these factors are propelling the rise in research and development investments. These investments are crucial for progressing the synthetic biology field’s capabilities to engineer biological systems and organisms to provide sustainable solutions in sectors such as healthcare, agriculture, and environmental management. As reported by the Office for National Statistics, in February 2024, the pharmaceutical product category led the business research and development investments in the UK in 2022, with an expenditure of $11.7 billion (£9.0 billion), which constituted 17.9% of UK businesses’ total R&D. This surge in research and development investment is hence enhancing the expansion of the synthetic biology market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2508&type=smp

How Is the Synthetic Biology Market Segments Structured?

The synthetic biology market covered in this report is segmented –

1) By Technology: Nucleotide Synthesis And Sequencing, Bioinformatics, Microfluidics, Genetic Engineering

3) By Product Type: Oligonucleotides, Enzymes, Cloning And Assembly Kits, Xeno-Nucleic Acids (XNA), Chassis Organism

2) By Application: Pharmaceuticals And Diagnostics, Chemicals, Biofuels, Bioplastics, Other Application

Subsegments:

1) By Nucleotide Synthesis And Sequencing: DNA Synthesis Technologies, Next-Generation Sequencing (NGS), Sanger Sequencing

2) By Bioinformatics: Software Tools For Genomic Data Analysis, Databases For Gene/Protein Information, Algorithms For Gene Editing And Design

3) By Microfluidics: Lab-On-A-Chip Technologies, Microfluidic Devices For Biological Assays, Applications In Drug Discovery And Diagnostics

4) By Genetic Engineering: CRISPR/Cas9 Technology, Recombinant DNA Technology, Synthetic Gene Construction And Assembly

What Strategic Trends Are Transforming the Synthetic Biology Market?

Recent advancements in DNA sequencing technology have opened up possibilities for researchers to utilize DNA as a means of storing non-genetic data. As the demand for data storage increases, the capacity of DNA data storage becomes more apparent and attractive. Each strand of DNA could potentially contain up to 455 Exabyte of information (equivalent to 455 billion gigabytes), a feat that has attracted substantial investments from market stakeholders. The process involves encoding binary data, which is written in 0s and 1s, into DNA strands of four specific base units (A, G, C, T) that comprise Adenine, Guanine, Cytosine, and Thymine (abbreviated as AGCT). Data coded in this way has a higher longevity, potentially lasting thousands of years, compared to data saved on traditional hard drives that deteriorate or become corrupted within approximately 30 years. By way of illustration, a study published in a journal by Nature Publishing Group highlighted an instance where Microsoft and University of Washington researchers managed to store 35 unique digital files in DNA, totalling more than 200 megabytes of data. There are plans to increase investment into this technology for further improvement.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

Which Global Regions Offer the Highest Growth in the Synthetic Biology Market?

North America was the largest region in the synthetic biology market in 2024. Western Europe was the second largest region in the global synthetic biology market share. The regions covered in the synthetic biology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2508

This Report Delivers Insight On:

1. How big is the synthetic biology market, and how is it changing globally?

2. Who are the major companies in the synthetic biology market, and how are they performing?

3. What are the key opportunities and risks in the synthetic biology market right now?

4. Which products or customer segments are growing the most in the synthetic biology market?

5. What factors are helping or slowing down the growth of the synthetic biology market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model